Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Merck Serono and BMS Team Up to Offer Diabetes Drug to China

publication date: Mar 20, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck Serono, a division of Merck KGaA, will collaborate with Bristol-Myers Squibb to promote China distribution of Glucophage®, the type 2 diabetes treatment known generically as metformin. Merck Serono discovered metformin in 1957. However, Bristol-Myers Squibb-SASS has been distributing the immediate-release formulation of the drug in China since 1999. The two companies will also introduce newer formulations of the drug to China. More details....

Stock Symbols: (F: MRK) (NYSE: BMY)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...